All Stories

  1. Therapeutic effect of pirfenidone in the sugen/hypoxia rat model of severe pulmonary hypertension

    Article • The FASEB Journal, November 2018, Federation of American Societies For Experimental Biology (FASEB)

    Laurent Savale, Christophe Guignabert, Ly Tu

  2. Expression ectopique du récepteur membranaire de l’interleukine 6 dans l’hypertension artérielle pulmonaire

    Article • médecine/sciences, October 2018, EDP Sciences

    Christophe Guignabert

  3. ACE2 as therapy for pulmonary arterial hypertension: the good outweighs the bad

    Article • European Respiratory Journal, June 2018, European Respiratory Society (ERS)

    Christophe Guignabert

  4. Dasatinib increases endothelial permeability leading to pleural effusion

    Article • European Respiratory Journal, January 2018, European Respiratory Society (ERS)

    Christophe Guignabert

  5. Role of Stromelysin 2 (Matrix Metalloproteinase 10) as a Novel Mediator of Vascular Remodeling Underlying Pulmonary Hypertension Associated With Systemic Sclerosis

    Article • Arthritis & Rheumatology, October 2017, Wiley

    Christophe Guignabert

  6. Vers de nouvelles cibles pour le traitement de l’hypertension artérielle pulmonaire : Importance des communications cellulaires

    Article • Biologie Aujourd hui, January 2016, EDP Sciences

    Christophe Guignabert

  7. Angiomatoid fibrous histiocytoma of the pulmonary artery: a multidisciplinary discussion

    Article • Histopathology, May 2014, Wiley

    Christophe Guignabert